Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy.

Bartlett EK, Gupta M, Datta J, Gimotty PA, Guerry D, Xu X, Elder DE, Czerniecki BJ, Fraker DL, Karakousis GC.

Ann Surg Oncol. 2014 Mar;21(3):1016-23. doi: 10.1245/s10434-013-3388-5. Epub 2013 Nov 21.

2.
3.

Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity.

Bartlett EK, Peters MG, Blair A, Etherington MS, Elder DE, Xu XG, Guerry D, Ming ME, Fraker DL, Czerniecki BJ, Gimotty PA, Karakousis GC.

Ann Surg Oncol. 2016 Jan;23(1):250-6. doi: 10.1245/s10434-015-4766-y. Epub 2015 Jul 28.

4.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039
5.

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.

Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72.

PMID:
21975320
6.

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Ann Surg Oncol. 2006 Dec;13(12):1655-63. Epub 2006 Oct 3.

PMID:
17016755
7.

Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.

Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF.

J Clin Oncol. 2012 Jul 20;30(21):2678-83. doi: 10.1200/JCO.2011.37.8539. Epub 2012 Jun 18.

PMID:
22711850
8.

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.

Mozzillo N, Pasquali S, Santinami M, Testori A, Di Marzo M, Crispo A, Patuzzo R, Verrecchia F, Botti G, Montella M, Rossi CR, Caracò C.

Eur J Surg Oncol. 2015 Jul;41(7):823-9. doi: 10.1016/j.ejso.2015.02.005. Epub 2015 Mar 11.

PMID:
25800935
9.

Observation after a positive sentinel lymph node biopsy in patients with melanoma.

Bamboat ZM, Konstantinidis IT, Kuk D, Ariyan CE, Brady MS, Coit DG.

Ann Surg Oncol. 2014 Sep;21(9):3117-23. doi: 10.1245/s10434-014-3758-7. Epub 2014 May 16.

PMID:
24833100
10.

Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.

Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE, Sussman JJ, Dirk Noyes R, Goydos JS, Beitsch PD, Ariyan S, Stromberg AJ, Hagendoorn LJ, McMasters KM.

Ann Surg Oncol. 2010 Mar;17(3):709-17. doi: 10.1245/s10434-009-0858-x. Epub 2009 Dec 5.

PMID:
19967459
11.

Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?

Ribero S, Osella-Abate S, Sanlorenzo M, Balagna E, Senetta R, Fierro MT, Macripò G, Macrì L, Sapino A, Quaglino P.

Ann Surg Oncol. 2015;22(6):1967-73. doi: 10.1245/s10434-014-4211-7. Epub 2014 Nov 12.

12.

Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.

Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.

J Clin Oncol. 2007 Mar 1;25(7):869-75.

PMID:
17327608
13.

Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.

Lee NC, Spillane AJ, Pang TC, Haydu LE, Uren RF.

Ann Surg Oncol. 2012 Jan;19(1):280-6. doi: 10.1245/s10434-011-1872-3. Epub 2011 Jul 21. Erratum in: Ann Surg Oncol. 2011 Dec;18 Suppl 3:S319-20.

PMID:
21833669
14.

Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.

Egger ME, Bhutiani N, Farmer RW, Stromberg AJ, Martin RC 2nd, Quillo AR, McMasters KM, Scoggins CR.

Surgery. 2016 May;159(5):1412-21. doi: 10.1016/j.surg.2015.12.002. Epub 2016 Jan 8.

PMID:
26775577
15.

Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older.

Sabel MS, Kozminski D, Griffith K, Chang AE, Johnson TM, Wong S.

Ann Surg Oncol. 2015 Jul;22(7):2112-9. doi: 10.1245/s10434-015-4539-7. Epub 2015 Apr 3.

PMID:
25834993
16.

Regional recurrence after negative sentinel lymph node biopsy for melanoma.

Carlson GW, Page AJ, Cohen C, Parker D, Yaar R, Li A, Hestley A, Delman KA, Murray DR.

Ann Surg. 2008 Sep;248(3):378-86. doi: 10.1097/SLA.0b013e3181855718.

PMID:
18791358
17.

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.

Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.

Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034. Epub 2009 Jun 22.

PMID:
19553103
18.

Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.

White RL Jr, Ayers GD, Stell VH, Ding S, Gershenwald JE, Salo JC, Pockaj BA, Essner R, Faries M, Charney KJ, Avisar E, Hauschild A, Egberts F, Averbook BJ, Garberoglio CA, Vetto JT, Ross MI, Chu D, Trisal V, Hoekstra H, Whitman E, Wanebo HJ, Debonis D, Vezeridis M, Chevinsky A, Kashani-Sabet M, Shyr Y, Berry L, Zhao Z, Soong SJ, Leong SP; Sentinel Lymph Node Working Group.

Ann Surg Oncol. 2011 Dec;18(13):3593-600. doi: 10.1245/s10434-011-1826-9. Epub 2011 Jun 7.

19.

Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.

Sartore L, Papanikolaou GE, Biancari F, Mazzoleni F.

Int J Surg. 2008 Jun;6(3):205-9. doi: 10.1016/j.ijsu.2008.03.003. Epub 2008 Mar 12.

20.

Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.

Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, Miller JR 3rd, Leong SP.

Arch Dermatol. 1998 Aug;134(8):983-7.

PMID:
9722728

Supplemental Content

Support Center